IKT President & CEO Provides a Brief Overview of the Company

Описание к видео IKT President & CEO Provides a Brief Overview of the Company

Dr. Milton H. Werner, Inhibikase CEO, highlights the Company's development of novel small-molecule kinase inhibitor therapeutics that have the potential to halt and reverse the progression of #neurodegenerative diseases including #ParkinsonsDisease and #AlzheimersDisease.

Комментарии

Информация по комментариям в разработке